CSIMarket Company Name, Ticker, Competitors, else..
 

Cohbar Inc   (NASDAQ: CWBR)

Cohbar Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

CWBR Sales vs. its Competitors Q2 2023


Comparing the current results to its competitors, Cohbar Inc reported Revenue decrease in the 2 quarter 2023 year on year by 0 %, slower than the combined decrease of the CWBR's competitors by -9.47 %, recorded in the same quarter.

• List of CWBR Competitors





Revenue Growth Comparisons




Net Income Comparison

Cohbar Inc , slower than the average decrease reported by the company's competitors of -55.39 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -55.39 %

<<  CWBR Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Cohbar Inc




Therapeuticsmd Inc
Share Performance



+4.35%
30 Days
Therapeuticsmd Inc
Profile

TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.

More about Therapeuticsmd Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 25.149 mill. $ 3.270 mill. $ -0.217 mill.


Acelyrin Inc
Share Performance



+11.00%
Over The Past 5 Days
Acelyrin Inc
Profile

Acelyrin Inc is a technology company that focuses on providing cutting-edge solutions in the healthcare industry. Their business model is centered around developing innovative software and hardware products that improve patient outcomes, enhance operational efficiency, and drive cost savings for healthcare organizations. By offering a range of advanced tools and services, Acelyrin Inc aims to revolutionize the healthcare sector and contribute to the overall advancement of digital health.

More about Acelyrin Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 228.544 mill. $ - mill. $ -268.517 mill.


Dianthus Therapeutics Inc
Share Performance



+164.04%
This Year
Dianthus Therapeutics Inc
Profile

Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.

More about Dianthus Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5,870.171 mill. $ 1.441 mill. $ -192.246 mill.


Medicure Inc
Share Performance



0.00%
30 Days
Medicure Inc
Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 25.925 mill. $ -5.920 mill.


Nexien Biopharma Inc
Share Performance



0.00%
Over The Past 5 Days
Nexien Biopharma Inc
Profile

Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.

More about Nexien Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.007 mill. $ - mill. $ -0.188 mill.

124 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Cohbar Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cohbar Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.